Skip to content
Home/Companies/MedTech/Verdot Ips²

Verdot Ips²

MedTech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Verdot Ips²?

Verdot Ips² is a French MedTech company, currently owned by Qualium Investissement since 2022.

Hand-verified · 3 sources · updated 2026-04-21

Open JSON · CC-BY
Qualium Investissement
Investor
Qualium Investissement
Qualium Fund III · 2023 · Buyout

Key facts

HQFrance
SectorMedTech

More from Qualium Fund III

Other portfolio companies in the same fund.

Avisia
Active
TMTFrance· 2025
Groupe Allen
Active
FinancialsFrance· 2025
IMPC
Active
HealthcareFrance· 2024
ChapsVision
ChapsVision
Active
SoftwareFrance· 2023
REALEASE
Realease
Active
FinancialsFrance· 2023
Realease Capital
Active
FinancialsFrance· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Verdot Ips²?

Verdot Ips² is currently owned by Qualium Investissement, through Qualium Fund III, since 2022.

When did Qualium Investissement acquire Verdot Ips²?

Qualium Investissement acquired Verdot Ips² in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue